Characterization of antecedent clonal hematopoiesis (CH) mutations in lymphoid and plasma cell neoplasms
Pinkal Desai(NewYork–Presbyterian Hospital), Gail J. Roboz(Cornell University), Lesley Tinker(Fred Hutch Cancer Center), Wodan Ling(Fred Hutch Cancer Center), Jonathan Canaani(NewYork–Presbyterian Hospital), Wendy Cozen(University of Southern California), Nuria Mencia-Trinchant(NewYork–Presbyterian Hospital), Andrea Sboner(Cornell University), Michael S. Samuel(Cancer Research UK Scotland Institute), Mónica L. Guzmán(NewYork–Presbyterian Hospital), Olivier Elemento(Cornell University), Ellen K. Ritchie(Cornell University), Michal Bar‐Natan(NewYork–Presbyterian Hospital), Zichan Li(Cornell University), Ying Li(North China Electric Power University), Kathryn Gorski(Cornell University)
Cited by 1
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Double-stranded DNA in exosomes: a novel biomarker in cancer detection
|Cell Research|2014|1.6k